Indegene

Indegene Current Ratio

The Current Ratio of Indegene (INDGN.NS) as of Oct 17, 2026 is 1.51. In the previous year, Current Ratio was 3.72 — a change of -59.48% (lower).

Current Ratio

1.51

YoY

-59.48%

Last updated:

Current Ratio of Indegene is 2026 1.51 . Current Ratio of Indegene was 2025 3.72 . It decreases by -59.48% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indegene Stock analysis

What does Indegene do? Indegene Ltd, headquartered in Bangalore, Karnataka, operates in the life sciences sector, providing digital-led commercialization services. The company supports biopharmaceutical, biotech, and medical device firms with drug development, clinical trials, regulatory submissions, pharmacovigilance, and sales marketing. Its Omnichannel Activation solutions optimize digital-first promotion to healthcare professionals, while Enterprise Commercial and Medical Solutions offer integrated digital marketing and regulatory operations for clients. Indegene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indegene stock

Current Ratio of Indegene is 1.51 in 2026.

Current Ratio of Indegene changed from 3.72 to 1.51, representing a -59.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Indegene since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Indegene with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Indegene

All Key Metrics — Indegene